|
The excitatory amino acids (EAAs), L-aspartic acid (L-Asp) and N-methy-D-aspartate (NMDA) on gastic acid secretion, signal transduction, and mucosal blood flow were investigated. Perfusion with L-Asp and NMDA did not modify the basal secretion of gastric acid. However, NMDA reduced the oxotremorine-, histamine-, and pentagestrin-stinulated acid secretion, while L-Asp markedly reduced histamine-stimulated acid secretion. These inhibitory effects of L-Asp and NMDA were blocked by AP-5 (2-amino-5-phosphovaleric acid) or CPP, the selective NMDA receptor antagonists. As for signal transduction, we separated rat stomach into two parts, muscle layer and mucosal layer (including submucosal connective tissue), and treated with various agonists and antagonists. It was found that both L-Asp and NMDA increased cGMP content of gastric mucosal cells dose-dependently, and this increasing effect could be blocked by NO synthase inhibitor L-NNA. Histamine evoked cAMP accumulation in gastric mucosal layer, but the cAMP accumultion was abolished by the presence of NMDA. Besides, L-Asp also inhibited the histamine-induced increase on gastric mucosal blood flow. The effet of L-Asp on gastric mucosal microcirculation was studied in the anesthetized rats by Laser Doppler Blood Flowmetry (LDF). L-Asp and NMDA did not significantly reduce both the mucosal and serosal blood flow of stomach. L-Asp and NMDA reduced histamine-induced increase in the gastric mucosal blood flow, but had no influence on serosal blood flow. AP-5 and prazosin reversed the inhibitory effect of L-Asp that suppressed the histamine-induced increase in the gastric blood flow. On the other hand, L-NAME (NG-ninto-L-arginine methyl eater) had no effect to the gastric mucosal blood flow. but reversed the inhibitory phenomenon of L-Asp to histamine-induced increase in the gastric mucosal blood flow. These results suggest that L-Asp and NMDA inhibit the histamine-induced acid secretion and increase of gastric mucosal blood flow. Furtherwore, NMDA also inhibits the exotremorine and pentagastrin-induced acid secretion. All these effects may be activated through NMDA receptor and cGMP-NO pathway, while mucosal blood flow is also regulated by adrenergic α1-receptor
|